IP Library Granted Patent US 10,844,388
Granted Patent B2
US 10,844,388 · App. 16/016,229 · Granted Nov 24, 2020

Replicative minicircle vectors with improved expression

Inventor: James A. Williams (Lincoln, NE)
Assignee: Nature Technology Corporation
C12N15/79C12N15/63C12N15/64C12N15/67C12N15/85C12P19/34C12P21/00A61K48/00C12N2800/107C12N2800/24C12N2820/55C12N2830/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,388
App. No.
16/016,229
Granted
Nov 24, 2020
Kind
B2
Abstract

A eukaryotic replicative pUC-free minicircle expression vector is provided. The eukaryotic replicative pUC-free minicircle expression vector includes a pUC-free eukaryotic region sequence encoding a transgene of interest and comprising 5′ and 3′ ends and ii) a pUC-free spacer region of less than 500 basepairs in length linking the 5′ and 3′ ends of the eukaryotic region sequences and comprising a bacterial R6K replication origin having at least 95% sequence identity to SEQ ID NO: 11 or SEQ ID NO: 12 and a RNA selectable marker, the RNA selectable marker being an RNA-IN regulating RNA-OUT functional variant having at least 95% sequence identity to SEQ ID NO:20 or SEQ ID NO:22.

Claims (8)

1. A eukaryotic replicative pUC-free minicircle expression vector comprising:

i) a eukaryotic region sequence encoding a gene of interest and comprising 5′ and 3′ ends; and

ii) a spacer region having a length of less than 500 basepairs that links the 5′ and 3′ ends of the eukaryotic region sequence and that comprises a R6K bacterial replication origin and a RNA selectable marker,

wherein the R6K bacterial replication origin has at least 95% sequence identity to SEQ ID NO: 11.

2. The vector of claim 1 , wherein said RNA selectable marker is a functional RNA-OUT with at least 95% sequence identity to a sequence selected from the group consisting of SEQ ID NO: 20 and SEQ ID NO: 22.

3. The vector of claim 1 , wherein said RNA selectable marker is selected from the group consisting of: an RNA-OUT selectable marker that encodes an RNA-IN regulating RNA-OUT RNA with at least 95% sequence identity to SEQ ID NO: 21; an RNAI selectable marker that encodes an RNAII regulating RNAI selectable marker encoding an RNAII regulating RNAI RNA with at least 95% sequence identity to SEQ ID NO: 35; an synthetic RNA selectable marker encoding an RNA selectable marker complement regulating RNA with at least 95% sequence identity to SEQ ID NO: 36.

4. The vector of claim 1 , wherein the RNA selectable marker is a functional RNA-OUT.

5. The vector of claim 1 , comprising the R6K bacterial replication origin and a RNA-OUT RNA selectable marker having at least 95% sequence identity to SEQ ID NO:21.

Assignments (2)
MERGER Recorded Feb 22, 2023
From: NATURE TECHNOLOGY CORPORATION
To: ALDEVRON, L.L.C.
Reel/Frame 062770/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2018
From: WILLIAMS, JAMES A.
To: NATURE TECHNOLOGY CORPORATION
Reel/Frame 046182/0042 →
Priority Claims (2)
WO PCT/US2013/000067 · Mar 14, 2013 · international
WO PCT/US2013/000068 · Mar 14, 2013 · international
Continuity (3)
Division 14432693
Provisional Application 61796765 · Nov 19, 2012
Related Publication 20180291385A1 · Oct 11, 2018
Cited By (2)
US 12,473,567 US 12,473,568